SpaCBA-OVA Liposome Reprograms Immune Tolerance to Ameliorate Allergic Rhinitis via DC-T Cell Crosstalk
{{output}}
Allergic rhinitis (AR) is a prevalent immune disorder driven by Th2-polarised inflammation, with current therapies primarily providing symptomatic relief rather than addressing the underlying immune dysfunction. Allergen-specific immunotherapy (AIT) holds prom... ...